Lupin's Shocking CDP 'A' Rating—What This Means for Your Future! Find Out Now!

Mumbai, January 24, 2026: In a significant achievement for environmental sustainability, Lupin Limited has been awarded the highest ‘A’ leadership rating from the Carbon Disclosure Project (CDP) for its performance in both Climate Change and Water Security. This prestigious recognition underscores the company’s commitment to transparency and responsible practices in managing climate risks and water resources.

The double ‘A’ rating places Lupin among a select group of global companies recognized for their leadership in environmental initiatives. This accolade is a reflection of the company's dedicated efforts to reduce carbon emissions and enhance water stewardship throughout its operations. The 2026 ratings represent a notable year-on-year improvement, following the 'A-' ratings in both categories in 2024, and previous scores of 'B' for climate and 'C' for water in 2023. Such consistent progress highlights enhancements in governance, quality of disclosure, and on-the-ground sustainability initiatives.

“As a global pharma leader, we have significantly advanced our efforts to reduce environmental impact through innovation, collaboration, and transparency. We are proud to have earned CDP’s Double ‘A’ rating,” said Ramesh Swaminathan, Executive Director, Global CFO, and Head of API Plus SBU at Lupin. He emphasized that the CDP's strict framework has been instrumental in shaping and accelerating the company's climate initiatives, fostering ongoing progress. “We are committed to establishing new sustainability standards and generating lasting value for our communities and the planet,” he added.

In addition to the CDP recognition, Lupin achieved an impressive S&P Global ESG score of 91 in 2025, placing it among a limited number of companies worldwide to surpass the 90-point benchmark. This combined performance underscores Lupin's integrated approach to addressing environmental, social, and governance (ESG) priorities, emphasizing its commitment to sustainability alongside business growth.

The CDP ratings are widely regarded as a global benchmark for environmental disclosure and performance, evaluating companies based on their transparency, risk management, and tangible actions in combating climate change and ensuring water security. Lupin's leadership rating not only solidifies its standing as a forward-thinking pharmaceutical company but also demonstrates the growing importance of corporate responsibility in today’s business landscape.

As businesses worldwide face increasing pressure to operate sustainably, Lupin serves as an example of how a proactive approach to environmental issues can lead to significant recognition and improvement in ESG performance. This accomplishment not only enhances the company's reputation but also aligns with a broader movement towards sustainability in the pharmaceutical industry and beyond.

Ultimately, the recognition from the CDP and the high ESG score from S&P Global signal that Lupin is not just committed to environmental stewardship, but is also positioning itself as a leader in a sector increasingly defined by its ability to innovate responsibly. As the landscape evolves, the expectations on companies to demonstrate genuine commitment to sustainability will only grow, making Lupin's achievements particularly noteworthy.